Abnormal electrochemical skin conductance in cystic fibrosis

Slides:



Advertisements
Similar presentations
J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Advertisements

Cheryl Cameron, Mark W. Lodes, William M. Gershan 
The prevalence of “risky behaviour” in adults with cystic fibrosis
Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus  Magnus Hillman, Leif Eriksson, Lena Mared, Karin Helgesson,
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
CFTR mutation in an Arab patient: Clinical and functional features of 875+1G→A/875+1G→A genotype  Elide Spinelli, Manuela Seia, Paola Melotti, Eleonora.
Sweat conductivity: An accurate diagnostic test for cystic fibrosis?
Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!  Clémence Martin, Cécile Hamard,
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis  Paul M. Beringer, Levita Hidayat, Anna Heed, Ling.
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Scott D. Sagel, Marci K. Sontag, Meg M
J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Nadav Traeger, Qiuhu Shi, Allen J. Dozor  Journal of Cystic Fibrosis 
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
Rate of improvement of CF life expectancy exceeds that of general population— Observational death registration study  Matthew N. Hurley, Tricia M. McKeever,
Controlled clinical trials in cystic fibrosis — are we doing better?
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance  L. Merjaneh, Q. He, Q. Long, L.S.
Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients  J.L. Fothergill,
Vitamin A and lung function in CF
The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation  Verena I. Seliger, David Rodman, Fredrick Van.
Pulmonary nocardiosis in cystic fibrosis
A.H. Gifford  Journal of Cystic Fibrosis 
Tregony Simoneau, Gregory S. Sawicki, Carly E. Milliren, Henry A
M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw 
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor  Meredith C. Fidler, Jack Beusmans, Paul Panorchan,
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Nasal polyposis in lung transplant recipients with cystic fibrosis
Hypertriglyceridemia is associated with insulin levels in adult cystic fibrosis patients  Marie-Claire Ishimo, Linda Belson, Sophie Ziai, Emile Levy, Yves.
Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients  E.B. Wilms, D.J. Touw, H.G.M. Heijerman 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Paternity in men with cystic fibrosis: a retrospective survey in France  Ingrid Duguépéroux, Dominique Hubert, Stéphane Dominique, Gil Bellis, Marc De.
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
A new method of sweat testing: the CF Quantum®sweat test
Determining presence of lung disease in young children with cystic fibrosis: Lung clearance index, oxygen saturation and cough frequency  E.M. Bakker,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Sophie Yammine, Florian Singer, Per Gustafsson, Philipp Latzin 
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
CFTR, investigated with the two-electrode voltage-clamp technique: the importance of knowing the series resistance  Georg Nagel  Journal of Cystic Fibrosis 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis  D.J. Touw, A.J. Knox,
Cystic fibrosis and pregnancy in the modern era: A case control study
R. D. Gray, M. Imrie, A. C. Boyd, D. Porteous, J. A. Innes, A. P
Safety assessment of inhaled xylitol in subjects with cystic fibrosis
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening  Fiona Cunningham, Sharon Lewis, Lisette.
Presentation transcript:

Abnormal electrochemical skin conductance in cystic fibrosis Dominique Hubert, Philippe Brunswick, Jean-Henri Calvet, Daniel Dusser, Isabelle Fajac  Journal of Cystic Fibrosis  Volume 10, Issue 1, Pages 15-20 (January 2011) DOI: 10.1016/j.jcf.2010.09.002 Copyright © 2010 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 General presentation of the device measuring electrochemical skin conductance. Hand and feet nickel electrodes and electronic board allowing voltage application, current and voltage measurements, recordings and data management. Journal of Cystic Fibrosis 2011 10, 15-20DOI: (10.1016/j.jcf.2010.09.002) Copyright © 2010 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Individual current density–voltage curves for a control subject (Ct, black squares) and a patient with cystic fibrosis (CF, black circles). Electrochemical skin conductance is the slope of the curve, i.e. the ratio between the current measured (Y-axis) and the difference in voltages obtained (∆anode−cathode: X-axis). ESC is the electrochemical skin conductance when a voltage of 1.6V was applied on the anode (i.e. the slope of the curve obtained at the 4th step of increasing voltage, corresponding to the 4th point of each curve). dESC is the difference between the electrochemical skin conductance obtained at 3.6V (i.e. the slope obtained when a voltage of 3.6V was applied on the anode, which was the 14th step of increasing voltage corresponding to the 14th point of each curve) and ESC (obtained at 1.6V). dESC is shown on the figure by the up down arrow. Journal of Cystic Fibrosis 2011 10, 15-20DOI: (10.1016/j.jcf.2010.09.002) Copyright © 2010 European Cystic Fibrosis Society. Terms and Conditions

Fig. 3 Electrochemical skin conductance measurements (ESC) when a voltage of 1.6V is applied on the anode for hands (A) and feet (B) in control subjects and patients with cystic fibrosis (CF). (The line for each group is the mean value; **: p<0.01; ****: p<0.0001). Journal of Cystic Fibrosis 2011 10, 15-20DOI: (10.1016/j.jcf.2010.09.002) Copyright © 2010 European Cystic Fibrosis Society. Terms and Conditions

Fig. 4 dESC on hands (A) and feet (B) in control subjects and patients with cystic fibrosis (CF). dESC is the difference between the electrochemical skin conductance obtained at 3.6V (i.e. the ratio between the current measured and (∆anode−cathode) obtained when a voltage of 3.6V was applied on the anode) and ESC (obtained at 1.6V). (The dotted line represents the cut-off of 60μSi; the line for each group is the mean value; ****: p<0.0001). Journal of Cystic Fibrosis 2011 10, 15-20DOI: (10.1016/j.jcf.2010.09.002) Copyright © 2010 European Cystic Fibrosis Society. Terms and Conditions

Fig. 5 Relation between sweat chloride concentrations and dESC for hands (A) and feet (B) in control subjects (squares) and patients with cystic fibrosis (diamonds). Journal of Cystic Fibrosis 2011 10, 15-20DOI: (10.1016/j.jcf.2010.09.002) Copyright © 2010 European Cystic Fibrosis Society. Terms and Conditions